EUVIMEDEUVIMED entdecken
Crossref

The Secretome of menstrual blood-derived endometrial stem cells ameliorates chemotherapy-induced ovarian injury by inhibiting necroptosis via the HSPA8-ATRIP axis

Yinglei Liu, Yu Sun, Jiongbo Zhao, Yijiao Wang, Deshang Xu, Jingwen Yan, Yilin Lu, Shuaipeng Zhou, Jie Lian, Ruyan Wan, Shenghui Zhang, Wenqiang Fan und 3 weitere

Cellular Signalling · 2027-01 · 149 · 112949

DOI: 10.1016/j.cellsig.2026.112949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2027-01. Verfasst von Yinglei Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Henan Joint International Research Laboratory of Stem Cell Medicine, School of Biomedical Engineering, Henan Medical University, Xinxiang, 453003, Ch…. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Henan Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy-induced ovarian injury poses a significant reproductive health challenge for young female cancer survivors, frequently resulting in premature ovarian insufficiency (POI) and infertility. This study demonstrates that menstrual blood-derived endometrial stem cells (MenSCs) and their conditioned secretome (MenSC-S) effectively ameliorate cisplatin-induced ovarian atrophy and functional decline, restoring primordial and growing follicle reserves and rescuing the expression of key functional biomarkers, including anti-Müllerian hormone (AMH), follicle-stimulating hormone receptor (FSHR), estrogen receptor alpha (ERα), and aromatase (Cyp19a1). Mechanistically, we show that chemotherapy induces a pathological shift toward necroptosis in ovarian granulosa cells (GCs) through activation of the RIPK1/RIPK3/p-MLKL signaling cascade, concomitant with suppression of the endogenous necroptosis inhibitor caspase8. We identify heat shock protein family A member 8 (HSPA8) as an indispensable paracrine mediator within MenSC-S that directly interacts with ATR-interacting protein (ATRIP) to establish a previously unrecognized regulatory axis. This physical HSPA8-ATRIP interaction is associated with reduced intracellular reactive oxygen species (ROS) accumulation and restoration of caspase8-mediated inhibition of necroptosis, thereby attenuating the necroptotic signaling cascade. Collectively, our findings support a cell-free therapeutic strategy that achieves efficacy comparable to MenSCs transplantation while offering enhanced biosafety and manufacturing standardization, thereby providing a robust theoretical and experimental foundation for the clinical translation of MenSC-based interventions in oncofertility.

Schlagwörter

Stichwörter der Autor:innen

ChemotherapyMenstrual blood-derived endometrial stem cellsNecroptosisOvarian dysfunctionSecretome

Autor:innen und Institutionen

  • Henan Joint International Research Laboratory of Stem Cell Medicine, School of Biomedical Engineering, Henan Medical University, Xinxiang, 453003, China; Collaborative Innovation Center of Stem Cell and Biotherapy, Hena…
  • Collaborative Innovation Center of Stem Cell and Biotherapy, Henan Medical University, Xinxiang, 453003, China; Henan Key Laboratory of Medical Tissue Regeneration, Henan Medical University, Xinxiang, 453003, China.
  • Collaborative Innovation Center of Stem Cell and Biotherapy, Henan Medical University, Xinxiang, 453003, China; Stem Cell and Biotherapy Technology Research Center, School of Life Science and Technology, Henan Medical U…
  • Collaborative Innovation Center of Stem Cell and Biotherapy, Henan Medical University, Xinxiang, 453003, China; The First clinical College of Henan Medical University, Xinxiang, 453003, China.
  • Collaborative Innovation Center of Stem Cell and Biotherapy, Henan Medical University, Xinxiang, 453003, China; Xinxiang Key Laboratory of Diagnosis of Autoimmune Diaease and Precision Pharmacotherapy, Xinxiang Central…
  • Collaborative Innovation Center of Stem Cell and Biotherapy, Henan Medical University, Xinxiang, 453003, China.

Förderung

  • National Natural Science Foundation of China
  • Henan Province Natural Science Foundation

Zitieren

APA

Liu, Y., Sun, Y., Zhao, J., Wang, Y., Xu, D., Yan, J., Lu, Y., Zhou, S., Lian, J., Wan, R., Zhang, S., Fan, W., Wang, W., Liu, Y., & Lin, J. (2027). The Secretome of menstrual blood-derived endometrial stem cells ameliorates chemotherapy-induced ovarian injury by inhibiting necroptosis via the HSPA8-ATRIP axis. Cellular Signalling, 149, 112949. https://doi.org/10.1016/j.cellsig.2026.112949

Vancouver

Liu Y, Sun Y, Zhao J, Wang Y, Xu D, Yan J, et al. The Secretome of menstrual blood-derived endometrial stem cells ameliorates chemotherapy-induced ovarian injury by inhibiting necroptosis via the HSPA8-ATRIP axis. Cellular Signalling. 2027;149:112949. doi:10.1016/j.cellsig.2026.112949

BibTeX
@article{Liu2027,
  author = {Liu, Yinglei and Sun, Yu and Zhao, Jiongbo and Wang, Yijiao and Xu, Deshang and Yan, Jingwen and Lu, Yilin and Zhou, Shuaipeng and Lian, Jie and Wan, Ruyan and Zhang, Shenghui and Fan, Wenqiang and Wang, Wenxiang and Liu, Yanli and Lin, Juntang},
  title = {The Secretome of menstrual blood-derived endometrial stem cells ameliorates chemotherapy-induced ovarian injury by inhibiting necroptosis via the HSPA8-ATRIP axis},
  journal = {Cellular Signalling},
  year = {2027},
  volume = {149},
  pages = {112949},
  doi = {10.1016/j.cellsig.2026.112949}
}
Kostenlos starten →